Nautilus Biotechnology, Inc. · NASDAQ:NAUT
AH Bio Fund II, L.P. sold 5,000,000 Nautilus Biotechnology, Inc. shares (Form 4)
Traded Jun 2, 2026 · Filed Jun 4, 2026
On Jun 2, 2026, AH Bio Fund II, L.P. (10% owner) sold 5,000,000 Nautilus Biotechnology, Inc. shares at US$2.35 for US$11.8M, leaving 971,885 shares. Filed Jun 4, 2026 (Form 4).
- Sold
- 5,000,000 shares
- Price
- US$2.35
- Value
- US$11.8M
- Holding after
- 971,885 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Common Stock | Sale | 4,615,974 | US$2.35 | 11,682,032 | Indirect |
| Jun 2, 2026 | Common Stock | Sale | 384,026 | US$2.35 | 971,885 | Indirect |
Source
Related
- Nautilus Biotechnology, Inc.
- AH Bio Fund II, L.P.
- Nautilus Biotechnology, Inc. shareholders
- Schedule 13D/A · Andreessen Marc L · Sep 11, 2026
- Schedule 13D/A · Andreessen Marc L · Aug 28, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13D/A · Andreessen Marc L · Jun 30, 2026
- Schedule 13D/A · Andreessen Marc L · Jun 4, 2026